MRSN

2.58

0.39% +0.01

Dopo l'orario di chiusura: 2.47 -0.11 -4.26%

Mersana Therapeutics Inc (MRSN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$2.57

Aprire:

$2.57

Volume 24 ore:

1.25M

Capitalizzazione di mercato:

$315.69M

Reddito:

$36.86M

Utile/perdita netta:

$-171.67M

Rapporto P/E:

-1.2647

EPS:

-2.04

Flusso di cassa netto:

$-171.05M

1 W Prestazione:

+4.67%

1M Prestazione:

-31.38%

6M Prestazione:

+67.53%

1 anno Prestazione:

-66.23%

Intervallo 1D:

$2.46

$2.63

Portata 52W:

$0.8014

$9.62

Mersana Therapeutics Inc Stock (MRSN) Company Profile

Nome

Mersana Therapeutics Inc

Settore

Healthcare (1212)

Industria

Biotechnology (697)

Telefono

617-498-0020

Indirizzo

840 Memorial Drive, Cambridge

Dipendente

Cinguettio

@MersanaADC

Prossima data di guadagno

2024-06-11

Ultimi documenti SEC

MRSN's Discussions on Twitter

Mersana Therapeutics Inc Stock (MRSN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-12-04	Aggiornamento	Citigroup	Neutral → Buy
2023-07-28	Downgrade	Robert W. Baird	Outperform → Neutral
2023-07-27	Downgrade	BTIG Research	Buy → Neutral
2023-07-27	Downgrade	Citigroup	Buy → Neutral
2023-07-27	Downgrade	Guggenheim	Buy → Neutral
2023-07-27	Downgrade	JP Morgan	Neutral → Underweight
2023-07-27	Downgrade	Truist	Buy → Hold
2023-07-27	Downgrade	Wedbush	Outperform → Neutral
2023-06-16	Downgrade	JP Morgan	Overweight → Neutral
2023-06-15	Iniziato	Guggenheim	Buy
2023-03-16	Aggiornamento	JP Morgan	Neutral → Overweight
2023-01-20	Iniziato	Citigroup	Buy
2022-11-21	Iniziato	Truist	Buy
2021-10-15	Ripresa	BTIG Research	Buy
2021-08-30	Iniziato	H.C. Wainwright	Buy
2021-03-31	Iniziato	Credit Suisse	Neutral
2020-12-03	Iniziato	Stifel	Buy
2020-09-29	Ripresa	JP Morgan	Neutral
2020-04-29	Iniziato	BTIG Research	Buy
2020-01-21	Reiterato	H.C. Wainwright	Buy
2019-03-11	Downgrade	JP Morgan	Neutral → Underweight
2018-11-14	Aggiornamento	Leerink Partners	Mkt Perform → Outperform
2018-05-08	Iniziato	Robert W. Baird	Outperform
2018-03-19	Downgrade	JP Morgan	Overweight → Neutral

Mostra tutto

Mersana Therapeutics Inc Borsa (MRSN) Ultime notizie

This trade activity should not be overlooked: Mersana Therapeutics Inc (MRSN) – Sete News - SETE News

SETE News

Mersana Therapeutics: On Hold While Waiting For Any Positive News (NASDAQ:MRSN) - Seeking Alpha

Seeking Alpha

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives Consensus Recommendation of "Moderate Buy" from ... - MarketBeat

MarketBeat

Technical analysis of Mersana Therapeutics Inc (MRSN) stock chart patterns – US Post News - US Post News

US Post News

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Defense World

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance

Yahoo Finance

Mersana Therapeutics Inc Azioni (MRSN) Dati Finanziari